PharmaTher (OTC:PHRRF) Shares Up 2% – Should You Buy?

PharmaTher Holdings Ltd. (OTC:PHRRFGet Free Report)’s share price was up 2% during trading on Monday . The company traded as high as $0.16 and last traded at $0.15. Approximately 38,610 shares changed hands during trading, a decline of 78% from the average daily volume of 173,512 shares. The stock had previously closed at $0.15.

PharmaTher Stock Up 2.0 %

The stock has a 50 day simple moving average of $0.14 and a two-hundred day simple moving average of $0.16.

About PharmaTher

(Get Free Report)

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.

Featured Stories

Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.